"CART Immunotherapy: Development, Success, and Translation to Malignant Gliomas and Other Solid Tumors." Filley AC et al. Front Oncol. 2018 Oct 17 Development of CART Immunotherapy (Fig 3) - 2017 FDA approval of CTL019 https://t.co/XwnEhn3KvG https://t.co/
586 followers
1,394 followers
RT @_atanas_: CART Immunotherapy: Development, Success, and Translation to Malignant Gliomas and Other Solid Tumors. - PubMed - NCBI https:…
2,006 followers
CART Immunotherapy https://t.co/ni1zfBfM0S
2,161 followers
RT @_atanas_: CART Immunotherapy: Development, Success, and Translation to Malignant Gliomas and Other Solid Tumors. - PubMed - NCBI https:…